|BRCA1 and 53BP1 regulate DNA double strand break repair pathway choice. BRCA1 (green) and 53BP1 (red) enrich in mutually exclusive yet associated subnuclear volumes at sites of DNA damage as determined by 3D structured illumination super-resolution microscopy (OMX, Applied Precision). BRCA1 enrichment at DNA damage sites in S-phase (pictured) antagonizes 53BP1 association with chromatin to enable DSB repair by homologous recombination.|
|Chromatin-dependent regulation of DNA repair. A dynamic competition between DNA repair factors and their residency in DNA damage-associated chromatin dictates DNA double-strand break repair pathway choice.|
|RIF1-deficiency in mice results in aberrant nucleolytic processing of DSBs during immunoglobulin class-switch recombination. Chromatin immunoprecipitation of the single stranded DNA binding protein RPA32 at Immunoglobulin heavy chain (IgH) and control (Rpp30) loci in stimulated primary B-cells.|
Chromatin and Genome Integrity
We aim to discover the function of molecular events propagated in chromatin upon DNA damage detection, and question why defects in these events manifest in immune-deficiency and cancer in humans.
DNA double-strand breaks (DSBs) are a highly toxic form of DNA damage, which if not properly repaired can result in mutations and genomic translocations. However, DSBs are also required during the specialized recombination events that generate diversity in our immune systems. Accordingly, cellular responses to DSBs are tightly regulated in a cell type and cell cycle dependent manner.
Two core regulators of DNA repair pathway choice are the BRCA1 and 53BP1 tumour suppressor proteins. Unlike core components of the DNA repair machinery that interact with or enzymatically process the DNA, these proteins exert their influence indirectly, interacting with large regions of chromatin spanning single DSBs. However, the respective activities of these proteins and nature of chromatin changes that are brought about by their enrichment at DNA damage sites remain undefined.
Recent research has revealed that BRCA1 functions to antagonize 53BP1-dependent DSB repair activities during S-phase. Furthermore, an inability to counteract 53BP1 results in the chromosomal instability and tumour predisposition evident in cellular and mouse models of Brca1-deficiency, respectively. Our recent work has focused on understanding the opposing molecular roles of the BRCA1 and 53BP1 proteins in regulating DNA double-strand break repair pathway choice. We have also recently identified RIF1 as the major effector protein during 53BP1-dependent non-homologous end joining, a process crucial for humoral immunity that also drives genomic instability in cells lacking functional BRCA1.
Using genome editing, transgenics and a combination of cell biology, biochemical, genetic and proteomic approaches, we are investigating the alterations that occur within DSB-associated chromatin as a result of the activities of these core proteins and other newly identified components of the DNA damage response. Moreover, we hope to elucidate how such changes determine DSB repair fate, to better understand why a breakdown in these processes can result in disease and cancer predisposition in humans.
Mechanism of 53BP1 activity regulation by RNA-binding TIRR and a designer protein.
Botuyan MV. et al, (2018), Nat Struct Mol Biol, 25, 591 - 600
The CST Complex Mediates End Protection at Double-Strand Breaks and Promotes PARP Inhibitor Sensitivity in BRCA1-Deficient Cells.
Barazas M. et al, (2018), Cell Rep, 23, 2107 - 2118
A map of human PRDM9 binding provides evidence for novel behaviors of PRDM9 and other zinc-finger proteins in meiosis
Altemose N. et al, (2017), ELIFE, 6
A map of human PRDM9 binding provides evidence for novel behaviors of PRDM9 and other zinc-finger proteins in meiosis.
Altemose N. et al, (2017), eLife, 6
Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility.
Wright DJ. et al, (2017), Nat Genet, 49, 674 - 679